scRNA-Seq analyses in non-EAC tumors has identified the VEGFA:TNF ratio as an important determinant of tumor progression and here we also observed dominant VEGFA expression, indicating a likely pro-tumoral role for mast cells in EAC, although trials of VEGF inhibitors in this setting have been largely disappointing [40]. This evidence concerns the gene TNF and neoplasm.